Squarepoint
PRCT icon

Squarepoint’s Procept Biorobotics PRCT Stock Holding History

Squarepoint’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,100
Closed -$974K – 5230
2024
Q4 		$974K Buy
12,100
+1,500
+14% +$128K ﹤0.01% 3090
2024
Q3 		$849K Buy
10,600
+6,200
+141% +$440K ﹤0.01% 2719
2024
Q2 		$269K Sell
4,400
-28,000
-86% -$1.67M ﹤0.01% 3494
2024
Q1 		$1.6M Buy
+32,400
New +$1.54M ﹤0.01% 2246

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Squarepoint's PRCT Position: Q2 2026 in Review

Squarepoint opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 26,430 shares worth $597K. The stake represents ﹤0.01% of the portfolio and ranks #3286 among its holdings. This is a return to the name: Squarepoint previously reported a position in PRCT as recently as Q4 2025.

Squarepoint first reported a position in PRCT in Q3 2021 and has held it in 13 quarters since. The position peaked at $12.9M in Q1 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Squarepoint held 26,430 shares of Procept Biorobotics worth $597K as of Q2 2026.
  • Procept Biorobotics was a new Squarepoint position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3286 holding.
  • Squarepoint first reported a position in Procept Biorobotics in Q3 2021 and has held it in 13 quarters since.
  • Squarepoint's Procept Biorobotics position peaked at $12.9M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.